Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


Purpose:

The purpose of this study is to confirm previous observations in asthmatics that chronic nadolol treatment reduces asthmatic airway hyper-responsiveness.


Criteria:

Inclusion Criteria: - Pre-bronchodilator FEV1 80% or greater than the predicted value. - PC20 FEV1 ≤4 mg/ml on methacholine challenge test. - Blood Pressure ≥ 100/65mm Hg. - Pulse rate ≥ 60 beats/min. - No significant health issues. - Non-smoker or X-smoker < 10 pack/year. Exclusion Criteria: - History of upper/lower respiratory tract infection or asthma exacerbation within 6 weeks of first baseline visit. - Currently diagnosed with chronic obstructive pulmonary disease (COPD). - Used any oral or inhaled corticosteroids within 4 weeks of the first baseline visit.


NCT ID:

NCT00670267


Primary Contact:

Principal Investigator
Richard A Bond, PhD
University of Houston


Backup Contact:

N/A


Location Contact:

Houston, Texas 77030
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.